After Hours Summary: CIDM -20.7%, BBBY -7.2%, MLHR -4.6%, FUL -1.7%, CWST -0.4% following earnings/guidance
After Hours Gainers:
Companies trading higher in after hours in reaction to news: IRM +22.6% (reported that the co is electing REIT status effective January 1, 2014), CJES +20.4% (entered into agreement to merge with Nabors Industries' (NBR) completion and production business in transaction valued at $2.86 bln), UNXL +17.7% (achieved roll-to-roll pilot production of InTouch Sensors), NBR +6.2% (confirmed agreement to combine its completion and production services business with C&J Energy Services (CJES)), WOR +1.4% (increased quarterly dividend 20% to $0.18 from $0.15 per share; Board authorized repurchase of up to an additional 10 mln common shares), MDT +1.2% (announced study results showing that continuous cardiac monitoring with the Reveal XT Insertable Cardiac Monitor was superior to standard of care)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: CIDM -20.7%, BBBY -7.2%, MLHR -4.6%, FUL -1.7%, CWST -0.4%
Companies trading lower in after hours in reaction to news: FUL -1.7% (signed agreement to acquire 95% of the equity of Tonsan for RMB 1.4 bln (~$230 mln); co also reported earnings), MRD -1.0% (priced private placement to eligible purchasers of $600 mln in aggregate principal amount of 5.875% senior unsecured notes due 2022 at par), GM -0.6% (seeing reports that co has told dealers to stop sales of Chevy Cruze due to potential problem with airbags)
Closing Market Summary: Stocks Climb Despite Disappointing Q1 GDP Revision
The stock market registered modest gains on Wednesday as participants looked past a pair of disappointing economic reports. The S&P 500 rose 0.5% with nine sectors ending higher, while the Nasdaq Composite (+0.7%) outperformed.
Prior to the open, the S&P 500 appeared to be on track for its third consecutive decline after first quarter GDP was revised down to -2.9% from -1.0% (Briefing.com consensus -1.8%). In addition, a more recent report—May Durable Orders—also surprised to the downside. Despite starting on a lower note, the major averages were able to rebound swiftly with the move likely supported by some short covering.
The health care sector (+1.1%) ended in the lead after showing relative strength throughout the session. The third-largest group was underpinned by solid gains in the shares of AbbVie (ABBV 54.97, +1.38) and Shire (SHPG 231.14, +7.87) amid reports AbbVie may submit an improved takeover proposal to Shire. However, Shire commented intraday, saying no changes have been made to the offer from May 30.
Even though the health care sector ended in the lead, biotechnology could not keep up. The iShares Nasdaq Biotechnology ETF (IBB 255.88, +0.79) added 0.3%.
Elsewhere, the consumer discretionary sector (+0.8%) lagged in the early going, but elbowed its way to the top of the leaderboard with help from media names after the Supreme Court ruled that start-up streaming service Aereo violated broadcaster copyright laws. CBS (CBS 62.48, +3.64) surged 6.2%, while Comcast (CMCSA 53.21, +0.57) and Disney (DIS 83.90, +1.22) advanced 1.1% and 1.5%, respectively.
Similar to the two top-weighted groups, the largest S&P 500 sector—technology (+0.6%)—also finished among the leaders. Google (GOOGL 585.93, +13.39) played a big part in the outperformance, rallying 2.3% as the company held its developers conference in San Francisco. Chipmakers, meanwhile, settled a bit behind the broader market (PHLX Semiconductor Index +0.4%).
One influential sector that could not finish among the other outperformers was the financial space (+0.1%). The sector underperformed for the second session in a row, but managed to narrow its week-to-date loss to 0.3%.
On the downside, the consumer staples sector spent the entire session climbing off lows, but still ended in the red (-0.1%) as General Mills (GIS 51.76, -1.94) weighed after reporting disappointing earnings.
Treasuries surged in reaction to this morning's data before erasing some of their gains in the afternoon. The 10-yr note added five ticks with its yield slipping two basis points to 2.56%.
Participation remained in line with recent averages as less than 650 million shares changed hands at the NYSE floor.
Economic data included Q1 GDP, May Durable Orders, and the weekly MBA Mortgage Index:Tomorrow, weekly initial claims (consensus 310K), May Personal Income (consensus 0.4%), Personal Spending (consensus 0.4%), and Core PCE Prices (consensus 0.2%) will all be announced at 8:30 ET.
- First quarter GDP growth was revised down from -1.0% in the second estimate to -2.9% in the third estimate. GDP increased 2.6% in Q4 2013. The consensus expected GDP to be revised down to -1.8%.
- In all likelihood that economic activity weakened because it was never on that strong of a footing to begin with. We've seen this play out over the past few years where growth in the first half of the year is much slower than expected.
- Real final sales were revised down to -1.3% from 0.6%. That was the first decline in real final sales since Q1 2011.
- Durable goods orders declined 1.0% in May after increasing an upwardly revised 0.8% (from 0.6%) in April. The consensus expected durable goods orders to increase 0.4%.
- Transportation orders fell 3.0% in May as orders of nondefense aircraft and parts fell 4.0%. The drop was unusual and can be blamed on seasonal adjustments. Boeing (BA 127.06, -2.09), which is heavily represented in the transportation data, reported solid gains in orders for May.
- Excluding transportation, durable goods orders declined 0.1% in May following a 0.4% increase in April, while the consensus expected these orders to increase 0.4%.
- The weekly MBA Mortgage Index fell 1.0% to follow last week's 9.2% decline.
- S&P 500 +6.0% YTD
- Nasdaq Composite +4.9% YTD
- Dow Jones Industrial Average +1.8% YTD
- Russell 2000 +1.7% YTD
Unusual Options Activity
Bullish Call Activity:Bearish Put Activity:
- NAT Jul 10 calls are seeing interest with relative strength in the underlying stock -- along with select shipping names following oil export news (volume: 4300, open int: 2870, implied vol: ~37%, prev day implied vol: 30%) -- co is expected to report earnings in Aug.
- MAN Jul 85 calls (volume: 3460, open int: 340, implied vol: ~22%, prev day implied vol: 19%) -- co is expected to report earnings mid July, possibly falling outside the July expirations cycle.
- BUD Sep 125 calls (volume: 12.5K, open int: 270, implied vol: ~21%, prev day implied vol: 19%) -- 7K contracts traded in single transaction above the offer. Co is confirmed to report earnings July 31 before the open.
- NEE Aug 105 calls (volume: 6530, open int: 3330, implied vol: ~18%, prev day implied vol: 17%) --nearly 5K traded at 1.15 with a 1.05/1.20 spread. CNBC discussed unusual options activity last week on June 19. Co is expected to report earnings late July.
Sentiment: The CBOE Put/Call ratio is currently: 0.78... VIX: (11.57, -0.56, -4.6%).
- CVRR Jul 25 puts are seeing interest with weakness in the underlying stock -- along with other refining related names -- and following offering news (volume: 2410, open int: 200, implied vol: ~25%, prev day implied vol: 20%) -- co is expected to report earnings late July.
- BGC Aug 25/26 puts are seeing interest. The BGC Aug 26 puts (volume: 3560, open int: 130, implied vol: ~40%, prev day implied vol: 36%) and the BGC Aug 25 puts (volume: 1450, open int: 240, implied vol: ~38%, prev day implied vol: 37%)
- HCA puts are seeing interest by nearly 3:1. Most notable volume is in the HCA Jan15 57.5 puts (volume: 7510, open int: 10, implied vol: ~23%, prev day implied vol: 22%) -- nearly all of the volume in the Jan15 57.5 puts occurred in single transaction.
July 18 is options expiration -- the last day to trade July equity options.
2014-06-25 15:12:57.198 GMT
By Allison Connolly
June 25 (Bloomberg) -- AbbVie can raise offer for Shire up
to GBP65/shr and maintain double-digit EPS accretion, assuming
4% debt rate, Jefferies says in note.
* Says for every GBP5/shr increase to its bid, AbbVie loses
~8-9 cents of accretion in 2020 vs the implied >$1.00 of
accretion at current stock price
* Expects AbbVie to raise offer until deal gets done
* Says promise of share buybacks is important for U.K.
shareholders who may not wish/won’t be able to hold AbbVie
stock
* Maintains buy rating, PT GBP66
* NOTE: Earlier, AbbVie CEO Won’t Rule Out Going Hostile for
Shire
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net
To contact the editor responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net